These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 16884869)
1. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869 [TBL] [Abstract][Full Text] [Related]
2. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060 [TBL] [Abstract][Full Text] [Related]
3. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465 [TBL] [Abstract][Full Text] [Related]
4. Sustained release of microbicides by newly engineered vaginal rings. Saxena BB; Han YA; Fu D; Rathnam P; Singh M; Laurence J; Lerner S AIDS; 2009 May; 23(8):917-22. PubMed ID: 19381077 [TBL] [Abstract][Full Text] [Related]
5. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy. Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074 [TBL] [Abstract][Full Text] [Related]
6. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069 [TBL] [Abstract][Full Text] [Related]
7. A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine. Major I; Boyd P; Kilbourne-Brook M; Saxon G; Cohen J; Malcolm RK Contraception; 2013 Jul; 88(1):58-66. PubMed ID: 23177261 [TBL] [Abstract][Full Text] [Related]
8. Advances in microbicide vaginal rings. Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066 [TBL] [Abstract][Full Text] [Related]
9. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093 [TBL] [Abstract][Full Text] [Related]
10. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. Gupta KM; Pearce SM; Poursaid AE; Aliyar HA; Tresco PA; Mitchnik MA; Kiser PF J Pharm Sci; 2008 Oct; 97(10):4228-39. PubMed ID: 18338805 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical development of microbicide drug products. Friend DR Pharm Dev Technol; 2010 Dec; 15(6):562-81. PubMed ID: 20017601 [TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. Nel A; Smythe S; Young K; Malcolm K; McCoy C; Rosenberg Z; Romano J J Acquir Immune Defic Syndr; 2009 Aug; 51(4):416-23. PubMed ID: 19623693 [TBL] [Abstract][Full Text] [Related]
13. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel. Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275 [TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287 [TBL] [Abstract][Full Text] [Related]
15. Sustained release of the candidate antiretroviral peptides T-1249 and JNJ54310516-AFP from a rod insert vaginal ring. Murphy DJ; Amssoms K; Pille G; Clarke A; O'Hara M; van Roey J; Malcolm RK Drug Deliv Transl Res; 2016 Jun; 6(3):234-42. PubMed ID: 26787615 [TBL] [Abstract][Full Text] [Related]
16. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES. McBride JW; Malcolm RK; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Devlin B; Boyd P Int J Pharm; 2019 Jun; 564():207-213. PubMed ID: 30999049 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of protein stability in rod-insert vaginal rings. Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955 [TBL] [Abstract][Full Text] [Related]
18. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring. McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates. Promadej-Lanier N; Smith JM; Srinivasan P; McCoy CF; Butera S; Woolfson AD; Malcolm RK; Otten RA J Med Primatol; 2009 Aug; 38(4):263-71. PubMed ID: 19476564 [TBL] [Abstract][Full Text] [Related]
20. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques. Moss JA; Malone AM; Smith TJ; Butkyavichene I; Cortez C; Gilman J; Kennedy S; Kopin E; Nguyen C; Sinha P; Hendry RM; Guenthner P; Holder A; Martin A; McNicholl J; Mitchell J; Pau CP; Srinivasan P; Smith JM; Baum MM Antimicrob Agents Chemother; 2012 Nov; 56(11):5952-60. PubMed ID: 22964245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]